• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Peregrine Pharmaceuticals Inc

+ Add to Watchlist

PPHM:US

1.4500 USD 0.0500 3.57%

As of 20:10:00 ET on 12/26/2014.

Snapshot for Peregrine Pharmaceuticals Inc (PPHM)

Open: 1.4100 Day's Range: 1.4000 - 1.4550 Volume: 817,849
Previous Close: 1.4000 52wk Range: 1.2700 - 3.1800 1-Yr Rtn: +5.07%

Stock Chart for PPHM

No chart data available.
  • PPHM:US 1.4500
  • 1D
  • 1M
  • 1Y
1.4000
Interactive PPHM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PPHM

Current P/E Ratio (ttm) -
Estimated P/E(04/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2700
Est. EPS (USD) (04/2015) -0.3000
Est. PEG Ratio -
Market Cap (M USD) 264.02
Shares Outstanding (M) 182.08
30 Day Average Volume 710,721
Price/Book (mrq) 3.9619
Price/Sale (ttm) 11.5066
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PPHM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PPHM

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the research, development and commercialization of novel therapeutics for cancer and a wide range of viral diseases.

Steven W KingPresident/CEOPaul J LytleChief Financial Officer
Mark R ZiebellVP/Secretary/General CounselShelley P M FusseyVP:Intellectual Property
More Company Profile & Key Executives for PPHM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil